Travere Therapeutics, Inc

TVTXNASDAQ · Pharmaceutical Preparations

Financing

SEC filings to 2026-10-05 · every row opens its filing

Shares on issue

94.2M

on 2026-06-30, from 76.1M on 2024-03-31 10-Q ↗

Newest

S-3ASR of 2024-08-01. Not read yet. S-3ASR ↗

4 of its filings are not read yet.

Warrants

The 10-Q filed 2026-08-04 is not read yet.

Cash

$293.6M

Operating cash flow was positive over the four quarters to 2026-06-30, so no quarters are counted. 10-Q ↗

Raised: 6 of its filings are not read yet.

Also on file: $475.0M convertible notes, 2026-05-06 424B5 ↗ · $50.0M convertible notes, 2026-05-06 8-K ↗